News and Events

We are thrilled to introduce Elizabeth Wanja Mathenge, MD, MSc, our new Oculofacial Plastic Surge

An important milestone for our patients: the FDA approval of the first treatment for a new disease indication, Macular Telangiectasia type 2 (MacTel).

Duke University School of Medicine received $455 million in federal funding from the National Institutes of Health (NIH) in 2024, according to the Blue Ridge Institute for Medical Research.

The annual meeting of the American Glaucoma Society (AGS) was held February 28 to March 2, 2025, in Washington, DC.

In a recent feature on PBS Carolina Impact, assistant professor of ophthalmology Oleg Alekseev, MD, PhD shares his expertise on retinitis pigmentosa (RP), a rare genetic condition that affects the retina and leads to progressive vision loss.

In addition to being a talented teacher, surgeon, and humanitarian, John Karickhoff, MD'64, HS‘64-'68, is a visionary.

We are thrilled to announce the addition of Can Kocasarac, MD, to the Duke Eye Center's esteemed neuro-ophthalmology team.

Several Duke Eye Center faculty and trainees participated in EnVision Summit 2025, held from February 14-17 in San Juan, Puerto Rico.

Several faculty and fellows from Duke Eye Center recently participated in the exclusive Vail Vitrectomy meeting, an invitation-only conference renowned for gathering the brightest minds in ophthalm

 

Duke Eye Center is thrilled to announce Duke Ophthalmology residency class of 2029.